Navigation Links
Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
Date:9/1/2009

About ProLindac(TM): ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion. Access has previously announced that it has licensed ProLindac to Aosaikang Medicinal Group ("ASK") for the Greater China Region and to JCOM, Ltd for South Korea. Under these agreements both of these partners will be conducting Phase 2 combination studies with ProLindac in specific tumor types at their expense based on these results.

About Access: Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and T
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NuAire Laboratory Economic Stimulus Package -- Free Accessories or Factory Options
2. One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions
3. Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights
4. Access Pharmaceuticals CEO Interviewed on Financial Website
5. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
6. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
7. Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress
8. Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China
9. Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
10. Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care
11. Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2014)... 2014 NSG Precision Cells has ... and spectrophotometer calibration standards for over ... released many products that have transformed the spectroscopy ... their solid-state calibration standards. , NSG’s solid-state calibration ... release in 2008. NSG started manufacturing UV ...
(Date:7/18/2014)... N.Y. , July 18, 2014 Regeneron ... its second quarter 2014 financial and operating results on ... open.  The Company will host a conference call and ... Conference Call InformationTo access this call, ... link to the webcast may be accessed from the ...
(Date:7/18/2014)... at Urbana-Champaign have demonstrated that an array of ... like traditional photographic film to record light for ... of light (for example, distances less than ~600 ... acts as a "nanocamera" whereas the pBNAs are ... the effect (writing and curing) is seen in ...
(Date:7/18/2014)... Reflecting the importance of the evolution of Houston’s real ... the founder and president of Customized Real Estate Services ... new approach to the firm’s branding. , According to ... success of his or her commercial clients have grown exponentially ... first in this market to fully embrace the potential for ...
Breaking Biology Technology:How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 3'Nanocamera' takes pictures at distances smaller than light's own wavelength 2LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2
... in medical device industry to benefit ... pharmaceutical clinical trial recruitment efforts, MINNEAPOLIS, May ... firm ThreeWire has strengthened the,pharmaceutical side of its ... development and a commitment to leveraging differentiators unique,to ...
... 27 Schering-Plough,Corporation (NYSE: SGP ) ... been,appointed vice president, investor relations, effective immediately., ... responsible for developing, implementing,and continually improving a ... will lead the formulation and execution of,external ...
... Collagen Matrix, Inc.,announced today that it has ... clearance of its TenoMend(TM) Collagen Tendon Wrap,indicated for ... which,there has been no substantial loss of tendon ... resorbable type 1 collagen,matrix that provides a non-constricting ...
Cached Biology Technology:ThreeWire Expands Presence in the Pharmaceutical Arena 2Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations 2Collagen Matrix, Inc. Receives FDA 510(k) Clearance for TenoMend(TM) Collagen Tendon Wrap for the Management and Protection of Tendon Injuries 2
(Date:7/22/2014)... New Rochelle, NY -- Stem cells offer much promise ... transplantation approaches stem cell survival is poor, limiting their ... improve the survival and optimize their therapeutic function after ... BioResearch Open Access , a peer-reviewed journal from Mary ... on the BioResearch Open Access website ...
(Date:7/22/2014)... have adapted to New York City,s human behaviour, allowing ... than their fellow squirrels in the woods. , Dr ... & Agriculture, led the study that proved eastern grey ... environments and prevent unnecessary responses when humans acted in ... , "As we rapidly increase the spread of ...
(Date:7/22/2014)... of meerkats which sees them prevent their daughters from ... new study. , Research into the desert creatures which ... adult helpers shows that the alpha female can flourish ... study shows how this way of life, also found in ... despite its sinister side. , Dominant meerkats control breeding ...
Breaking Biology News(10 mins):New York squirrels are nuts about city life 2
... of a novel genome mapping method to humans, ... cost-effective tool than traditional DNA sequencing. , A ... USC University Professor in molecular and computational biology, ... amounts of data created by a restriction mapping ...
... he started compiling an online database of seashells 15 ... his meticulous record-keeping would eventually shed light on a ... underlying the island rule: that small animals isolated on ... and large animals evolve to be smaller. In a ...
... called GB Virus type C (GBV-C) protects against HIV infection ... Affairs (VA) Iowa City Health Care System and the University ... HIV from growing in cell models. , The team found ... called NS5A greatly slows down HIV from replicating in cells ...
Cached Biology News:Powerful genome ID method extended to humans 2Scientist's persistence sheds light on marine science riddle 2Study IDs protein that inhibits HIV from growing in cell cultures 2Study IDs protein that inhibits HIV from growing in cell cultures 3